Ancillary Home Airway Clearance in CF Patients ( HomeCareSIMEOX )
NCT04095078 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56
Last updated 2022-01-04
Summary
Regular bronchial clearance is essential in patients with cystic fibrosis for their bronchial health. SIMEOX® (Physio-Assist, Aix en Provence, France) is an innovative medical device for the drainage of the bronchial tree. By changing the rheological properties of mucus, SIMEOX® helps to mobilize secretions and assists their transport to the upper airways. This technology is based on fundamental research on bronchial mucus rheology. At the present time, SIMEOX® device is mainly used over a short period at the time or after an exacerbation in healthcare structures (hospitals, physiotherapy practices, postcare, and rehabilitation units, etc…). The clinical effects observed in the short term encourages long-term autonomous use by the patients themselves. The overall objective of this study is to evaluate the efficiency and acceptability of SIMEOX® used at home by the patient himself for bronchial clearance in patients with cystic fibrosis.
Conditions
- Pulmonary Cystic Fibrosis
Interventions
- DEVICE
-
SIMEOX
Use without obligation, in autonomous and at home of the bronchial clearance device: SIMEOX
Sponsors & Collaborators
-
Icadom
collaborator INDUSTRY -
Physio-Assist
lead INDUSTRY
Principal Investigators
-
Boubou Camara, MD · CHUGA
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-10
- Primary Completion
- 2021-09-15
- Completion
- 2021-12-15
Countries
- France
Study Locations
More Related Trials
-
Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic Fibrosis
NCT03357913 ·Status: COMPLETED
-
Muco Smartphone Exacerbation
NCT02122289 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Performances and Safety of MuCopilot, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis
NCT06147778 ·Status: COMPLETED ·Phase: NA
-
Continuous Cardiorespiratory Monitoring in Cystic Fibrosis
NCT04489186 ·Status: COMPLETED ·Phase: NA
-
Self Drainage in Pediatric Cystic Fibrosis Patients
NCT01509235 ·Status: COMPLETED ·Phase: NA
-
Home Monitoring to Predict Exacerbation in Cystic Fibrosis
NCT02416375 ·Status: COMPLETED
-
Feasibility of Cough Monitoring in Children
NCT06587126 ·Status: RECRUITING
-
A Short-term Comparative Study of Aerosure for Airway Clearance in Patients With Cystic Fibrosis
NCT01923753 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation
NCT02709109 ·Status: COMPLETED ·Phase: PHASE2
-
Determinants of Daily Physical Activity Level in Patients With Cystic Fibrosis - Pilot Study Protocol
NCT05206097 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic Fibrosis
NCT00970346 ·Status: COMPLETED ·Phase: PHASE1
-
Electro Flo 5000 and Vest Therapy
NCT02277626 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Airway Clearance Efficacy of Two High Frequency Chest Wall Oscillation (HFCWO) Devices in Cystic Fibrosis
NCT00308958 ·Status: COMPLETED ·Phase: NA
-
Researching the Effects of Airway Clearance Therapies in Cystic Fibrosis
NCT03078127 ·Status: COMPLETED ·Phase: NA
-
A Decentralized Study to Evaluate Physical Activity and Cough Frequency Using Wearable Technology in Cystic Fibrosis
NCT04923464 ·Status: COMPLETED
-
A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device
NCT02141191 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis
NCT04396366 ·Status: TERMINATED ·Phase: PHASE2
-
Correction of Nonsense Mutations in Cystic Fibrosis
NCT03670472 ·Status: RECRUITING
-
Evaluation of Device Settings for Airway Clearance Using The Monarch Airway Clearance System
NCT03645473 ·Status: UNKNOWN ·Phase: NA
-
Early Intervention in Cystic Fibrosis Exacerbation
NCT01104402 ·Status: COMPLETED ·Phase: NA
-
Long Term Significance (Survival) of LCI in Patients With Cystic Fibrosis
NCT01951833 ·Status: WITHDRAWN
-
PEP and OPEP Devices in Cystic Fibrosis
NCT05801952 ·Status: UNKNOWN ·Phase: NA
-
Educational Program Through Video Conference for Inhaled Therapies in Cystic Fibrosis Patients
NCT03850145 ·Status: COMPLETED
-
Evaluation of Nebulization and Positive Expiratory Pressure Combination
NCT02535130 ·Status: UNKNOWN ·Phase: NA
-
Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF)
NCT02343445 ·Status: COMPLETED ·Phase: PHASE2